Diagnosis and Treatment in Internal Medicine (eBook, PDF)

Redaktion: Davey, Patrick; Sprigings, David

• Format: PDF

Produktbeschreibung

Diagnosis and Treatment in Internal Medicine equips trainee doctors with the essential skills and core knowledge to establish a diagnosis reliably and quickly, before outlining the management of the clinical condition diagnosed. Organised into three sections, the first provides a vital overview, whilst the second focuses on common presentations and diagnoses. Uniquely, this new book shows readers how to turn symptoms into a list of diagnoses ordered by probability - a differential diagnosis. Experienced consultants who teach trainees every day demonstrate how to derive an ordered differential diagnosis, how to narrow this down to a single diagnosis and if not, how to live with diagnostic uncertainty. The final section provides a comprehensive account of the management of system-based syndromes and diseases. Highly-structured chapters emphasize how common conditions present, how to approach a diagnosis, and how to estimate prognosis, treatment and its effectiveness. An onus is placed on the development of crucial diagnostic skills and the ability to devise evidence-based management plans quickly and accurately, making this an ideal text for core medical trainees.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Oxford University Press
• Seitenzahl: 1280
• Erscheinungstermin: 6. September 2018
• Englisch
• ISBN-13: 9780192520777
• Artikelnr.: 54574213

Autorenporträt

Patrick Davey DM FRCP is a consultant cardiologist at Northampton General Hospital and former training program director General Medicine for the East Midlands. His subspecialty interests include nuclear cardiology and coronary intervention. He studied undergraduate medicine at Cambridge, clinical medicine at Oxford, undertook SHO jobs in Leicester, and then trained in cardiology at Papworth, and returned to Oxford for research, and as senior registrar and senior lecturer. He has been a consultant cardiologist at Northampton since 2000. He is the editor of a number of bestselling textbooks including Medicine at a Glance, ECG at a Glance, amongst others. David Sprigings qualified from Oxford University Medical School and trained in internal medicine and cardiology in Oxford and London. He was a consultant physician and cardiologist at Northampton General Hospital from 1993 to 2016. From 2017 he has been a locum consultant cardiologist at John Radcliffe Hospital Oxford. His interests include electronic diagnostic systems to support the generalist, value-based healthcare, and the integration of primary and secondary care in cardiology.

Inhaltsangabe

* Part 1 The approach to the patient
* 1: Diagnostic reasoning
* 2: Dealing with uncertainty
* 3: Taking the history
* 4: The physical examination
* 5: The psychological examination
* 6: Confidentiality
* 7: Consent
* Part 2 Assessment of symptoms and presenting problems
* 8: Palpitation
* 9: Acute chest pain
* 10: Chronic chest pain
* 11: Hypotension
* 12: Acute breathlessness
* 13: Chronic breathlessness
* 14: Peripheral oedema
* 15: Murmur
* 16: Cough
* 17: Wheeze
* 18: Haemoptysis
* 19: Pleural effusion
* 20: Chylothorax
* 21: Difficulty swallowing
* 22: Haematemesis
* 23: Acute abdominal pain
* 24: Chronic abdominal pain
* 25: Dyspepsia
* 26: Abdominal mass
* 27: Constipation
* 28: Acute diarrhoea
* 29: Chronic diarrhoea
* 30: Rectal bleeding
* 31: Jaundice
* 32: Ascites
* 33: Chylous ascites
* 34: Swelling in the neck
* 35: Splenomegaly and other disorders of the spleen
* 36: Lymphadenopathy
* 37: Anaemia
* 38: Bruising and bleeding
* 39: Transient loss of consciousness
* 40: Coma
* 41: Delirium (Acute confusional state)
* 42: Seizures
* 43: Difficulty speaking (including dysphasia and dysarthria)
* 44: Weakness
* 45: Tremor and other abnormal movements
* 46: Gait disorders
* 47: Sensory loss
* 48: Headache
* 49: Loss of vision
* 50: The red eye
* 51: Hearing loss
* 52: Facial pain
* 53: Dizziness
* 54: Disorders of sleep
* 55: Haematuria
* 56: Oliguria and anuria
* 57: Polyuria
* 58: Dysuria
* 59: Urinary incontinence
* 60: Faecal incontinence
* 61: Vaginal discharge
* 62: Joint pain
* 63: Muscle pain
* 64: Low back pain
* 65: Painful leg
* 66: Leg ulcer
* 67: Limb ischaemia
* 68: Rashes
* 69: Blistering rashes
* 70: Photosensitive rashes
* 71: Itching
* 72: Lumps and bumps
* 73: Falls
* 74: Immobility ( Off legs )
* 75: Suspected anaphylaxis
* 76: Fever
* 77: Hyperthermia
* 78: Hypothermia
* 79: Fatigue
* 80: Unintentional weight loss
* 81: Obesity
* 82: Self-harm
* 83: Alcohol intoxication
* 84: Intravenous drug use
* Part 3 Cardiovascular disorders
* 85: Normal function of the cardiovascular system
* 86: Risk factors for cardiovascular disease
* 87: Diagnosis and investigation in suspected heart disease
* 88: Congenital heart disease in adults
* 89: Chronic stable angina
* 90: Acute coronary syndromes
* 91: Acute heart failure
* 92: Chronic heart failure
* 93: Aortic stenosis
* 94: Aortic regurgitation
* 95: Mitral regurgitation
* 96: Miscellaneous valvar pathology: mitral stenosis, pulmonary
stenosis, and tricuspid regurgitation
* 97: Percutaneous coronary interventions
* 98: Heart surgery
* 99: Circulatory support therapy
* 100: Pulmonary hypertension
* 101: Venous thrombosis and pulmonary embolism
* 102: Aortic aneurysm
* 103: Aortic dissection
* 104: Peripheral arterial disease
* 105: Raynaud's phenomenon
* 106: Heart muscle disease (cardiomyopathy)
* 107: Tumours and the heart
* 108: Cardiac infection
* 109: Pericardial disease
* 110: Extrasystoles
* 111: Sinus tachycardia
* 112: Focal (ectopic) atrial tachycardia (FAT/EAT)
* 113: Multifocal atrial tachycardia (MAT)
* 114: Atrioventricular nodal re-entrant tachycardia (AVNRT)
* 115: Atrioventricular re-entrant tachycardia (AVRT)
* 116: Atrial fibrillation
* 117: Atrial flutter
* 118: Ventricular tachyarrhythmias: ventricular tachycardia and
ventricular fibrillation
* 119: Bradyarrhythmias
* 120: Sudden cardiac death
* 121: Cardiac device therapy
* 122: Drug-induced cardiovascular disease
* 123: Psychological management of coronary heart disease
* 124: Treatment of terminal cardiovascular disease
* Part 4 Respiratory disorders
* 125: Normal respiratory function
* 126: Diagnosis in suspected respiratory disease
* 127: Investigation in respiratory disease
* 128: Upper respiratory tract infection, including influenza
* 129: Pneumonia
* 130: Tuberculosis
* 131: Pneumothorax
* 132: Cystic fibrosis
* 133: Asthma
* 134: Chronic obstructive pulmonary disease
* 135: Respiratory failure
* 136: Obstructive sleep apnoea
* 137: Bronchiectasis
* 138: Sarcoidosis and other granulomatous lung disease
* 139: Interstitial lung disease
* 140: Pulmonary vasculitis
* 141: Lung cancer (including management of an isolated lung lesion)
* 142: Occupational lung disease
* 143: Pleural infection and malignancy
* 144: Drug-induced lung disease
* 145: Psychology in respiratory disease including dysfunctional
breathing
* 146: Terminal care in respiratory illness
* Part 5 Intensive care medicine
* 147: Critical illness
* 148: Role of the intensive care unit
* 149: ICU treatment of respiratory failure
* 150: ICU treatment of cardiovascular failure
* 151: ICU treatment of renal failure
* 152: ICU treatment of sepsis and septic shock
* 153: Terminal care in the intensive care unit
* 154: Brain death
* Part 6 Disorders of the kidney and urinary tract
* 155: Normal renal function
* 156: Diagnosis in suspected renal disease
* 157: Investigation in renal disease
* 158: Urinary tract infection
* 159: Glomerulonephritis
* 160: Interstitial renal disease
* 161: Nephrotic syndrome
* 162: Acute renal failure
* 163: Chronic kidney disease
* 164: Diabetic renal disease
* 165: Urinary tract obstruction and tumours
* 166: Renal calculi
* 167: Renal and bladder cancer
* 168: Renal support therapy
* 169: Inherited renal diseases
* 170: The kidney in systemic disease
* 171: Renal vascular disease
* 172: Management of terminal care in renal disease
* 173: Disorders of plasma potassium
* 174: Disorders of plasma sodium
* 175: Disorders of plasma calcium
* 176: Disorders of plasma phosphate
* 177: Disorders of plasma magnesium and other elements
* 178: Disorders of acid-base balance
* 179: Porphyria
* 180: Aminoacidopathies, urea cycle disorders and organic acidurias
* 181: Amyloidosis
* Part 7 Diabetes mellitus and endocrine disorders
* 182: Normal function of the endocrine system
* 183: Diagnosis and investigation in endocrine disorders
* 184: Diabetes mellitus
* 185: Hypoglycaemia
* 186: Thyroid disease
* 187: Primary hyperparathyroidism
* 188: Adrenal disease
* 189: Cushing syndrome
* 190: Short stature
* 191: Infertility
* 192: Pituitary disorders: prolactinomas, acromegaly and pituitary
apoplexy
* Part 8 Gastro-intestinal disorders
* 193: Normal gastrointestinal function
* 194: Diagnosis in suspected gastrointestinal disease
* 195: Investigation in gastrointestinal disease
* 196: Immunology and genetics in gastrointestinal and hepatic medicine
* 197: Gastrointestinal infections
* 198: Benign oesophageal disease
* 199: Peptic ulcer disease
* 200: Gall bladder disease
* 201: Pancreatic disease
* 202: Malabsorption
* 203: Inflammatory bowel disease
* 204: Gastrointestinal tumours
* 205: Functional gastrointestinal diseases
* 206: Psychiatry in gastrointestinal medicine
* Part 9 Disorders of the liver
* 207: Normal hepatic function
* 208: Investigation in liver disease
* 209: Acute liver failure
* 210: Chronic liver failure
* 211: Alcoholic liver disease
* 212: Viral hepatitis
* 213: Auto-immune hepatitis
* 214: Genetic liver disease
* 215: Drug-induced liver disease
* 216: Miscellaneous liver diseases
* 217: The liver in systemic disease
* 218: Liver cancer
* Part 10 Neurological disorders
* 219: Normal neurological function
* 220: Diagnosis in suspected neurological disease
* 221: Investigation in neurological disease
* 222: Demographics of neurological disease
* 223: Neurogenetic disease
* 224: Neuro-cutaneous syndromes
* 225: Congenital neurological disorders
* 226: Epilepsy
* 227: Stroke
* 228: Dementia
* 229: Neurological infection
* 230: Disorders of movement
* 231: Multiple sclerosis
* 232: Motor neurone disease
* 233: Spinal cord disease
* 234: Neuropathy
* 235: Myopathy
* 236: Vasculitis in neurology
* 237: Neurological tumours
* 238: Non-metastatic neurological manifestations of malignancy
* 239: Neurosurgery
* 240: Drug-induced neurological disease
* 241: Functional and dissociative neurological symptoms
* 242: Palliative care in neurological disease
* Part 11 Disorders of the skin
* 243: Normal skin function
* 244: Approach to diagnosing skin disease
* 245: Investigation in skin disease
* 246: Skin infection and infestation
* 247: Cutaneous vasculitis
* 248: Acne
* 249: Psoriasis
* 250: Eczema
* 251: Urticaria
* 252: Bullous disorders
* 253: Hair disorders
* 254: Nail disorders
* 255: Mucosal disease
* 256: Genital disease
* 257: Polymorphic light eruption and actinic prurigo
* 258: Disorders of pigmentation
* 259: Skin cancer
* 260: Skin markers of internal disease
* 261: Drug-induced skin disease
* 262: Psychocutaneous medicine
* Part 12 Disorders of the musculoskeletal system
* 263: Normal function of the musculoskeletal system
* 264: Diagnosis in suspected rheumatological disease
* 265: Investigation in rheumatological disease
* 266: Osteoarthritis
* 267: Rheumatoid arthritis
* 268: Sero-negative spondylarthropathy
* 269: Systemic lupus erythematosus
* 270: Crystal arthropathy
* 271: Infection of joints and bones
* 272: Vasculitis
* 273: Osteomalacia
* 274: Paget's disease of bone
* 275: Osteoporosis and fragility fracture
* 276: Genetic bone and joint disease
* Part 13 Haematological disorders
* 277: Normal blood function
* 278: Diagnosis and investigation in haematology
* 279: Haematinic-deficiency anaemia
* 280: Haemolytic anaemia
* 281: Normal platelet function
* 282: Platelet disorders
* 283: Normal haemostatic function
* 284: Bleeding disorders
* 285: Prothrombotic conditions
* 286: Acute leukaemia
* 287: Chronic leukaemia
* 288: Myelodysplasia
* 289: Lymphoma
* 290: Multiple myeloma and related conditions
* 291: Myeloproliferative disorders
* 292: Terminal care in haematological disease
* Part 14 Disorders of the immune system
* 293: Functions of the immune system
* 294: Clinical features and diagnosis of immunological disease
* 295: Neutrophil abnormalities
* 296: Human immunodeficiency virus (HIV) infection
* 297: Antibody deficiencies
* 298: Combined T and B cell immunodeficiencies
* 299: Complement deficiencies
* 300: Hypersensitivity diseases
* 301: Immunological support
* 302: Immunosuppressive therapy and therapeutic monoclonal antibodies
* Part 15 Infectious diseases
* 303: Defences against infection
* 304: Nature and demographics: Epidemiology of infective organisms
* 305: Diagnosis in suspected infective disease: The history and
examination
* 306: Investigation in infection
* 307: Treatment of infection
* 308: Viral infection
* 309: Sepsis
* 310: Bacterial infection
* 311: Mycobacterial infection other than tuberculosis
* 312: Spirochaetal infection (non-syphilis)
* 313: Syphilis
* 314: Rickettsial infection
* 315: Fungal infection
* 316: Protozoal infection: Gut organisms
* 317: Protozoal infection: Malaria
* 318: Worm infection (including hydatid disease)
* 319: Prion disease
* 320: Sexually-transmitted disease (gonorrhoea)
* Part 16 Cancers
* 321: Cancers related to infection
* 322: Principles of oncogenesis
* 323: Presentations in suspected cancer
* 324: Diagnosis and staging of cancer
* 325: Treatment of cancer
* 326: Prostate cancer
* 327: Breast cancer
* 328: Ovarian and testicular cancer
* 329: Symptom-control in cancer
* 330: Dying from cancer
* Part 17 Dietary, lifestyle and environmental factors affecting health
* 331: Normal nutritional function
* 332: Starvation and malnutrition
* 333: Vitamin deficiencies
* 334: Nutritional support in the critically ill
* 335: Poor diets
* 336: Obesity
* 337: Physical activity and its role in disease prevention
* 338: Smoking
* 339: Alcohol
* 340: Environmental radiation
* 341: Air pollution
* 342: Non-prescription drugs
* Part 18 Prevention of disease
* 343: Prevention of cardiovascular disease
* 344: Prevention of respiratory disease
* 345: Prevention of kidney disease
* 346: Prevention of gastrointestinal disease
* 347: Prevention of neurological disease
* 348: Prevention of cerebrovascular disease
* 349: Prevention of infection
* 350: Prevention of cancer
* Part 19 Screening for disease
* 351: Screening for cardiovascular disease
* 352: Screening for respiratory disease
* 353: Screening for kidney disease
* 354: Screening for gastrointestinal disease
* 355: Screening for neurological disease
* 356: Screening for cancer